Literature DB >> 35796796

Annexin A5 suppression promotes the progression of cervical cancer.

Xiaojie Wang1, Yarui Dai1, Jialu Zhang1, Xin Li2.   

Abstract

BACKGROUND: Cervical cancer is a common malignant gynecological disease that threatens the health of women all over the world. The abnormal expression of Annexin A5 (ANXA5) is closely related to the biological behavior of various malignant tumors, however, the relationship between ANXA5 and cervical cancer is still unclear. Therefore, the effects of low expression of ANXA5 on the proliferation, apoptosis, migration and invasion of cervical cancer cells (HeLa) and its related mechanism were explored.
METHODS: The cells were divided into three groups: ANXA5-si group, negative control group and blank group. RNA interference was used to suppress ANXA5 expression. 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, colony formation assay, flow cytometry and propidium iodide (PI) staining, wound healing assay and transwell assay were employed to detect cell proliferation, apoptosis, migration and invasion respectively. Meanwhile, gene expression was detected by qPCR and Western blotting.
RESULTS: ANXA5 suppression lead to the increase of proliferation, migration, invasion and the decrease of apoptosis of cervical cancer HeLa cells. Furthermore, the expression of both pPI3K and pAkt increased.
CONCLUSION: ANXA5 might inhibit Hela cells proliferation and metastasis by regulating PI3K/Akt signal pathway.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Annexin A5; Cervical cancer; Metastasis; PI3K/Akt pathway; Proliferation

Year:  2022        PMID: 35796796     DOI: 10.1007/s00404-022-06524-1

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  18 in total

Review 1.  Annexin A5 as a potential marker in tumors.

Authors:  Boya Peng; Chunmei Guo; Hongwei Guan; Shuqing Liu; Ming-Zhong Sun
Journal:  Clin Chim Acta       Date:  2013-10-08       Impact factor: 3.786

2.  Effects of silencing annexin A5 on proliferation and invasion of human cholangiocarcinoma cell line.

Authors:  X-M Ding; J-X Li; K Wang; Z-S Wu; A-H Yao; C-Y Jiao; J-J Qian; D-S Bai; X-C Li
Journal:  Eur Rev Med Pharmacol Sci       Date:  2017-04       Impact factor: 3.507

3.  Annexin V expression on CD4+ T cells with regulatory function.

Authors:  Anna-Lena Bollinger; Thomas Bollinger; Jan Rupp; Kensuke Shima; Natalie Gross; Laura Padayachy; Rachel Chicheportiche; Gisella L Puga Yung; Jörg Dieter Seebach
Journal:  Immunology       Date:  2019-11-20       Impact factor: 7.397

4.  Glucocorticoid resistance induced by ANXA5 overexpression in B-cell acute lymphoblastic leukemia.

Authors:  Ju Yang; Ping Liu; Dan Ma; Peng Zhao; Yan Zhang; Yinghao Lu; Yanju Li; Yi Huang; Ying Chen; Jishi Wang
Journal:  Pediatr Hematol Oncol       Date:  2020-11-24       Impact factor: 1.969

5.  Novel Injury Site Targeted Fusion Protein Comprising Annexin V and Kunitz Inhibitor Domains Ameliorates Ischemia-Reperfusion Injury and Promotes Survival of Ischemic Rat Abdominal Skin Flaps.

Authors:  Victor Bong-Hang Shyu; Chung En Hsu; Chih-Jen Wen; Tze-Chein Wun; Rui Tang; Samuel Achilefu; Fu-Chan Wei; Hui-Yun Cheng
Journal:  Ann Plast Surg       Date:  2017-03       Impact factor: 1.539

6.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.

Authors:  Hyuna Sung; Jacques Ferlay; Rebecca L Siegel; Mathieu Laversanne; Isabelle Soerjomataram; Ahmedin Jemal; Freddie Bray
Journal:  CA Cancer J Clin       Date:  2021-02-04       Impact factor: 508.702

7.  High Annexin A5 expression promotes tumor progression and poor prognosis in renal cell carcinoma.

Authors:  Jingyuan Tang; Zhiqiang Qin; Peng Han; Wei Wang; Chengdi Yang; Zhen Xu; Ran Li; Bianjiang Liu; Chao Qin; Zengjun Wang; Min Tang; Wei Zhang
Journal:  Int J Oncol       Date:  2017-04-03       Impact factor: 5.650

Review 8.  Extracellular annexin A5: functions of phosphatidylserine-binding and two-dimensional crystallization.

Authors:  Hugo O van Genderen; Heidi Kenis; Leo Hofstra; Jagat Narula; Chris P M Reutelingsperger
Journal:  Biochim Biophys Acta       Date:  2008-02-20

9.  Annexin A5 regulates hepatocarcinoma malignancy via CRKI/II-DOCK180-RAC1 integrin and MEK-ERK pathways.

Authors:  Xujuan Sun; Shuqing Liu; Jinxia Wang; Bin Wei; Chunmei Guo; Chen Chen; Ming-Zhong Sun
Journal:  Cell Death Dis       Date:  2018-05-25       Impact factor: 8.469

10.  Annexin A5 suppresses cyclooxygenase-2 expression by downregulating the protein kinase C-ζ-nuclear factor-κB signaling pathway in prostate cancer cells.

Authors:  Hyoung-Seok Baek; Nahee Park; Yeo-Jung Kwon; Dong-Jin Ye; Sangyun Shin; Young-Jin Chun
Journal:  Oncotarget       Date:  2017-07-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.